Physician profile
Jordan Michael Chaisson
NPI 1871869990
$46,496.83
in general payments reported to CMS, 2019-2025
30 companies · $1,076 in 2025
The $1,076 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $7,462 · 2021: $3,270 · 2022: $2,149 · 2023: $887 · 2024: $1,530 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,990 · Travel and Lodging: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,990.10 |
| Travel and Lodging | $503.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,561.53 | 2019-2025 | Ensite, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $14,650.44 | 2019-2020 | |
| Boston Scientific Corporation | $6,625.27 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr, Farawave |
| Biotronik INC. | $3,365.44 | 2019-2023 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $1,515.53 | 2019-2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $863.86 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $439.34 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $356.08 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $300.57 | 2019-2020 | |
| Medical Device Business Services, INC. | $299.99 | 2020 | |
| Irhythm Technologies, INC. | $218.37 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $215.64 | 2021-2025 | Linq II |
| Amgen INC. | $201.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $168.85 | 2019-2021 | |
| Cardiva Medical, INC. | $152.07 | 2019-2024 | Ensoetm |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $146.31 | 2019-2020 | |
| Astellas Pharma US INC | $89.96 | 2019-2020 | |
| Chiesi USA, INC. | $51.75 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $37.37 | 2023 | Optimizer |
| Portola Pharmaceuticals, LLC | $37.21 | 2019-2020 | |
| Edwards Lifesciences Corporation | $28.57 | 2024 | Hemosphere |
| Shockwave Medical, INC | $26.58 | 2022 | |
| Abiomed | $24.85 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $22.00 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $21.44 | 2024 | |
| W. L. Gore & Associates, INC. | $17.27 | 2020 | |
| Terumo Medical Corporation | $16.85 | 2021 | |
| Esperion Therapeutics, INC. | $15.57 | 2024 | Nexletol |
| Merck Sharp & Dohme LLC | $14.25 | 2024 | Verquvo |
| Pfizer INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Chaisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.